A study of bioavailabilities and dissolution rates of commercial tablets of nitrofurantoin.
D001702:Biopharmaceutics; D006801:Humans; D009325:Nausea / Q000139:chemically induced; D009582:Nitrofurantoin / Q000009:adverse effects / Q000097:blood / Q000378:metabolism* / Q000652:urine; D012995:Solubility; D013607:Tablets
D013607:Tablets; D009582:Nitrofurantoin